top of page
    • Sep 26

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective Therapeutics. Then, Jay Olson highlights ADC targets to watch while highlighting Bicycle and Sutro.



Brought to you by:


Comments

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE

bottom of page